DAFTAR PUSTAKA

4
DAFTAR PUSTAKA Bastuji-Garin, et al. 1993. Clinical Classification of Cases of Toxic Epidermal Necrolysis, Stevens- Johnson Syndrome, and Erythema Multiforme. Arch Dermatol 129 (1) : 92-96. Bastuji-Garin, S. 2000. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol. 115:149-53. Budimulja, U.; L. S. Selamat. 1998. Epidemiology of Drug Eruption and Skin Testing with Drugs in Indonesia. Environ Dermatol 5(Suppl 2) : 63-68. Chopra, et al. 2004. Stevens-Johnson Syndrome After Immunization with Smallpox, Anthrax, and Tetanus Vaccines. Mayo Clin Proc 79 : 1193-1196. Cohen, B. 2000. Stevens-Johnson Syndrome. Johns Hopkins University. Available at: http://dermatlas.med.jhmi.edu/derm/display.cfm? ImageID=54 (diakses 22 April 2014). Dunant, et al. 2002. Correlations Between Clinical Patterns and Causes of Erythema Multiforme Majus, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis. Arch Dermatol 138 : 1019-1024. Emond, R.T.D.; H.A.K. Rowland, P. D. Welsby. 1995. Colour Atlas of Infectious Diseases. 3 th ed. Barcelona: Mosby-Wolfe.

description

nokmkom

Transcript of DAFTAR PUSTAKA

Page 1: DAFTAR  PUSTAKA

DAFTAR PUSTAKA

Bastuji-Garin, et al. 1993. Clinical Classification of Cases of Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome, and Erythema Multiforme. Arch Dermatol 129 (1) : 92-96.

Bastuji-Garin, S. 2000. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol. 115:149-53.

Budimulja, U.; L. S. Selamat. 1998. Epidemiology of Drug Eruption and Skin Testing with Drugs in Indonesia. Environ Dermatol 5(Suppl 2) : 63-68.

Chopra, et al. 2004. Stevens-Johnson Syndrome After Immunization with Smallpox, Anthrax, and Tetanus Vaccines. Mayo Clin Proc 79 : 1193-1196.

Cohen, B. 2000. Stevens-Johnson Syndrome. Johns Hopkins University. Available at: http://dermatlas.med.jhmi.edu/derm/display.cfm?ImageID=54 (diakses 22 April 2014).

Dunant, et al. 2002. Correlations Between Clinical Patterns and Causes of Erythema Multiforme Majus, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis. Arch Dermatol 138 : 1019-1024.

Emond, R.T.D.; H.A.K. Rowland, P. D. Welsby. 1995. Colour Atlas of Infectious Diseases. 3th ed. Barcelona: Mosby-Wolfe.

Fagot, et al. 2001. Nevirapine and the Risk of Sevens-Johnson Syndrome or Toxic Epidermal Necrolysis. AIDS 15 (14). 1843-1848.

Foster, et al. 2005. Stevens-Johnson Syndrome. Available at: http://emedicine.medscape.com/article/1197450-overview (diakses 22 April 2014).

Fitzpatrick, T.B., et al. 1999. Fitzpatrick’s Dermatology in General Medicine. 5 th

edition. The McGraw-Hill.

Fritsch, P. O.; A. Sidoroff. 2000. Drug Induced Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis. J Clin Dematology American 1 (6) : 349-360.

Page 2: DAFTAR  PUSTAKA

Ghislain, P.D.; J.C. Roujeau. 2005. Treatment of Severe Drug Reactions : Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis and Hypersensitivity Syndrome. Dermatology Online Journal 8 (1) : 5.

Hamzah, M. 2002. Ilmu Penyakit Kulit dan Kelamin. Edisi 5. Jakarta: Fakultas Kedokteran Universitas Indonesia.

Jones, et al. 2004. Early Diagnosis Is Key in Vancomycin-Induced Linear IgA Bullous Dermatosis and Stevens-Johnson Syndrome. JAOA 104 : 157-163.

Labreze, et al. 2000. Diagnosis, Classification, and Management of Erythema Multiforme and Stevens-Johnson Syndrome. Arch Dis Child 83 : 347-352.

Landow, R. K. 1983. Kapita Selekta terapi Dermatologik. Diterjemahkan oleh Petrus A. Jakarta: CV EGC.

Levene, G.M.; C.D. Calnan. 1989. Atlas Berwarna Dermatology. Diterjemahkan oleh Drs. Med. Adji Dharma. Jakarta: Penerbit Buku Kedokteran EGC.

Lim, A.S.M.; I.J. Constable. 1987. Colour Atlas of Opthalmology. 2nd. Singapore.

Lynch. 1994. Burket’s Oral Medicine Diagnosis and Treatment. 9 th ed. Philadelphia: J. B. Lippincot Co. 20-22.

Mansjoer, dkk. 2000. Kapita Selekta Kedokteran. Edisi ketiga Jilid 2. Jakarta: Penerbit Media Aesculapius. 136-138.

Martodihardjo, S. dkk. 1990. Sindroma Stevens-Johnson dalam Aspek Klinis dan Patologi. Surabaya: Fakultas Kedokteran Universitas Airlangga.

Namayanja, G.K, et al. 2005. Stevens-Johnson Syndrome Due to Nevirapine. Uganda. Makarere Medical School.

Noel, M. V., Sushma, S. Giudo. 2000. Cutaneous Adverse Drug Reactions in Hospitalized Patients in a Tertiary Care Center. J. Pharmacol Indian 36 (5) : 292-295.

Parillo, et al. 2005. Stevens-Johnson Syndrome. Available at: http://www.eMedicine.com (diakses 22 April 2014)

Parillo, S.J. 2009. Stevens-Johnson Syndrome: Follow-up. Philadelphia University. Available at : http://emedicine.medscape.com/article/756523-followup (diakses 22 April 2014).

Perdoski. 2003. Standar Pelayanan Medik Ilmu Kesehatan Kulit dan Kelamin. Jakarta: Perdoski. 38-40.

Page 3: DAFTAR  PUSTAKA

Roujeau, J.C.; R.S. Stern. 1994. Severe Adverse Cutaneous Reactions to Drugs. Arch Dermatol 331 (19) : 1272-1285.

Roujeau, et al. 1995. Medication Use and the Risk of Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis. NEJM 333 (24) : 1600-1608.

Sharma, V.K.; G.G. Sethuraman. 1996. Adverse Cutaneous Reaction to Drugs: an overview. J Postgard Med 42 (1): 15-22.

Shuen Lam, et al. 2004. Clinical Characteristic of Childhood Erythema Multiforme, Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Taiwanese Children. J Microbiol Immunol Infect 37: 366-370.

Siregar, R.S. 1996. Atlas Berwarna Saripati Penyakit Kulit. Edisi 2. Jakarta: EGC. Hal: 141-142; 163-165.

Smelik, M. 2005. Stevens-Johnson Syndrome : A Case Study. Available at: http://xnet.kp.org/permanentejournal/winter02/casestudy.html (diakses 22 April 2014).

Sularsito, S.A.; R.W. Soebaryo; Kuswadji. 1986. Dermatologi Praktis. Edisi pertama. Jakarta: Perkumpulan Ahli Dermato-Venereologi Indonesia.

Tong Chen, et al. 2003. Outbreak of Stevens-Johnson Syndrome/ Toxic Epidermal necrolysis Associated with Mevendazole and Metronidazole Use among Filipino Labores in Taiwan. J Public Health American 93 (3): 489-492.

Villar, et al. 2001. Case report : Positive Patch Test with Phenytoin in a Case of Stevens-Johnson Syndrome. J alergol Immunol Clin 16 : 174-176.